Sort
15,842 grants matching “pancreatic cancer”
Specific Targets for Pancreatic Cancer Therapy
$229,073Ramzi M. Mohammad · Wayne State University · R01 · FY2008 · CA
Single molecule microarrays for the detection of mutant DNA in body fluids
$228,939Alfredo Andres Celedon · Scanogen, Inc. · R21 · FY2013 · CA
TGFBeta1 signaling and radiation response in pancreas CA
$228,936University Of Kentucky · R01 · FY2003 · CA
Project #2
$228,920Emmanuel O Akala · Howard University · U54 · FY2024 · CA
Project 2: Intratumoral PDT Induces PDP-based Enhancement of PD-1 Inhibition in Pancreatic Carcinoma
$228,869Kenneth K Wang · Massachusetts General Hospital · P01 · FY2022 · CA
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer
$228,855Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2017 · CA
Personalized Organoid-Chip Model For Drug Testing in Pancreatic Cancer
$228,839Faraz Bishehsari · Rush University Medical Center · R21 · FY2023 · CA
Admin Supplement FoxO signaling and skeletal muscle atrophy
$228,753Andrew Robert Judge · University Of Florida · R01 · FY2020 · AR
Microbiota pancreas interactions during cancer
$228,750June Louise Round · University Of Utah · R21 · FY2021 · CA
The Role of Myc in ChREBP-dependent, Glucose-stimulated Gene Expression
$228,739Donald K Scott · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · DK
Genomics Core Facility
$228,725Michael D Topal · Univ Of North Carolina Chapel Hill · P30 · FY2014 · CA
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB
$228,534University Of California San Francisco · R37 · FY2001 · AI
Pancreas cancer combination therapy based on stromal modulators and nano-carriers
$228,508Robert M Straubinger · State University Of New York At Buffalo · R21 · FY2012 · CA
Aim protein-based anti-inflammatory therapeutic for the treatment of IBD
$228,409Catherine Pohl Robinson · Keybiome Llc · R41 · FY2023 · DK
DEVELOPMENT OF TECHNETIUM-99M LABELED PEPTIDE TRACERS
$228,401Johns Hopkins University · P01 · FY2001 · CA
Prognostic potential of low-level mutations in meylodysplastic syndrome
$228,375G. Mike Makrigiorgos · Dana-Farber Cancer Inst · R21 · FY2015 · CA
Identification of Plasma- and Exosome-Based Protein Biomarkers for Early Detection of Pancreatic Cancer Using SOMAscan Technology
$228,375Towia A Libermann · Beth Israel Deaconess Medical Center · R21 · FY2018 · CA
Photodynamic Priming for Bidirectional Modulation of Drug Transport Across the Blood-Brain Tumor Barrier
$228,335Huang Chiao Huang · Univ Of Maryland, College Park · R21 · FY2021 · EB
Hedgehog Acyltransferase as a target in cancer
$228,310Marilyn D Resh · Sloan-Kettering Inst Can Research · R21 · FY2014 · CA
CC: Clinical Research
$228,162Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2011 · CA
An Integrated Microfluidics Platform for Rapid and Sensitive Exosome RNA
$228,000Hsueh-Chia Chang · University Of Notre Dame · R21 · FY2016 · HG
Education and Outreach Unit
$227,988Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2016 · CA
Administrative and Biostatistics Core
$227,918Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2023 · CA
The Macropinosome: Uncovering the Molecular Anatomy of an Oncogene-driven Organelle
$227,906Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2021 · CA
A novel gene therapy approach targeting STING-silenced cold tumors
$227,906Jianxin You · University Of Pennsylvania · R21 · FY2023 · CA